AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18950331 — intervention group
Group type: COMPARATOR
Intervention: Balanced general anesthesia with remifentanil
Number of subjects: 62
Study 16022917 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine 30 mg/m² D1,8 with Carboplatin AUC 5 D1 (VC)
Number of subjects: 316
Study 16022917 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinorelbine 25 mg/m² with Gemcitabine 1000 mg/m² (VG)
Number of subjects: 316
Study 16022917 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine 30 mg/m² with Carboplatin (VC)
Number of subjects: 316
Study 16022917 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinorelbine 25 mg/m² with Gemcitabine (VG)
Number of subjects: 316
Study 12955634 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg levofloxacin per day for 5 days
Number of subjects: 390
Study 12955634 — intervention group
Group type: COMPARATOR
Intervention: 500 mg levofloxacin per day for 10 days
Number of subjects: 390
Study 10618536 — intervention group
Group type: EXPERIMENTAL
Intervention: MMR-Vax(R)
Number of subjects: 766
Study 10618536 — intervention group
Group type: EXPERIMENTAL
Intervention: Pluserix(R)
Number of subjects: 766
Study 10618536 — intervention group
Group type: EXPERIMENTAL
Intervention: Triviraten(R)
Number of subjects: 766
Study 10618536 — intervention group
Group type: EXPERIMENTAL
Intervention: MMR-Vax(R) and Pluserix(R) (revaccination)
Number of subjects: 766
Study 10618536 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level antibodies (defined as 0.15<0.40 IU/ml for measles, 1:230<=1:500 for mumps, and 7-16 IU/ml for rubella)
Number of subjects: 766
Study 10618536 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level antibodies
Number of subjects: 766
Study 8692415 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive peridural scar
Number of subjects: 197
Study 8692415 — intervention group
Group type: COMPARATOR
Intervention: Less extensive peridural scar
Number of subjects: 197
Study 1802186 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous feeding without energy-dense food promotion
Number of subjects: 88
Study 1802186 — intervention group
Group type: COMPARATOR
Intervention: Meals before spontaneous feeding instructions
Number of subjects: 88
Study 1802186 — intervention group
Group type: EXPERIMENTAL
Intervention: Meals after spontaneous feeding instructions
Number of subjects: 88
Study 6351957 — intervention group
Group type: EXPERIMENTAL
Intervention: sulphamethoxazole 1000 mg twice daily for 7 days
Number of subjects: 109
Study 6351957 — intervention group
Group type: EXPERIMENTAL
Intervention: trimethoprim (160 mg)‐sulphamethoxazole (800 mg) (TMP‐SMX) twice daily for 7 days
Number of subjects: 109
Study 6351957 — intervention group
Group type: EXPERIMENTAL
Intervention: sulphamethoxazole
Number of subjects: 109
Study 6351957 — intervention group
Group type: EXPERIMENTAL
Intervention: trimethoprim alone
Number of subjects: 109
Study 30894442 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted age at puberty (1-year increase)
Number of subjects: 329245
Study 30894442 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariable MR analysis controlling for adult BMI
Number of subjects: 329245
Study 30894442 — intervention group
Group type: EXPERIMENTAL
Intervention: Incorporation of childhood BMI in multivariable MR analysis
Number of subjects: 329245
Study 30015550 — intervention group
Group type: EXPERIMENTAL
Intervention: Li quick repositioning maneuver
Number of subjects: 120
Study 30015550 — intervention group
Group type: COMPARATOR
Intervention: Barbecue repositioning maneuver
Number of subjects: 120
Study 27567423 — intervention group
Group type: EXPERIMENTAL
Intervention: F(ab)2 antivenom
Number of subjects: 21
Study 24064386 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment group
Number of subjects: 0
Study 24064386 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 22119854 — intervention group
Group type: EXPERIMENTAL
Intervention: Cartomerge
Number of subjects: 97
Study 22119854 — intervention group
Group type: COMPARATOR
Intervention: NavX Fusion
Number of subjects: 97
Study 19419338 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate nasal spray (FFNS) 110 microg once daily
Number of subjects: 302
Study 19419338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302
Study 17484585 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotype threat made salient by reminding participants of male achievement in mathematics (Experiment 1)
Number of subjects: 747
Study 17484585 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotype threat (Experiment 2)
Number of subjects: 747
Study 14694242 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone (1500 microg/day)
Number of subjects: 18
Study 14694242 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (1600 microg/day)
Number of subjects: 18
Study 14694242 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 14694242 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone and Budesonide
Number of subjects: 18
Study 16290729 — intervention group
Group type: EXPERIMENTAL
Intervention: Prototype blackcurrant drink
Number of subjects: 0
Study 16290729 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothkind blackcurrant drink
Number of subjects: 0
Study 16290729 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange juice
Number of subjects: 0
Study 16290729 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral water
Number of subjects: 0
Study 10505557 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral levofloxacin plus intermittent intraperitoneal (IP) vancomycin
Number of subjects: 101
Study 10505557 — intervention group
Group type: COMPARATOR
Intervention: IP netromycin plus intermittent IP vancomycin
Number of subjects: 101
Study 10505557 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral levofloxacin plus intermittent IP vancomycin
Number of subjects: 101
Study 8089288 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2a (3 MU subcutaneously three times per week, increased to 12 MU, total dose of 216 MU over 2 months)
Number of subjects: 14
Study 8089288 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2a (9 MU once a month continued in half the patients)
Number of subjects: 14
Study 2684306 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acyclovir
Number of subjects: 27
Study 2684306 — intervention group
Group type: COMPARATOR
Intervention: Intravenous acyclovir
Number of subjects: 27
Study 57444 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractionated insulin preparations (Nordisk Insulin Ltd)
Number of subjects: 6
Study 31037340 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy-based ready-to-use therapeutic food (S-RUTF)
Number of subjects: 260
Study 31037340 — intervention group
Group type: COMPARATOR
Intervention: Milk-based ready-to-use therapeutic food (M-RUTF)
Number of subjects: 260
Study 30506579 — intervention group
Group type: EXPERIMENTAL
Intervention: ACh (endothelium-dependent dilator) during exercise
Number of subjects: 7
Study 30506579 — intervention group
Group type: COMPARATOR
Intervention: Sodium nitroprusside (SNP; endothelium-independent dilator) during exercise
Number of subjects: 7
Study 30506579 — intervention group
Group type: EXPERIMENTAL
Intervention: KCl infusion in quiescent muscle
Number of subjects: 7
Study 28984822 — intervention group
Group type: EXPERIMENTAL
Intervention: Walnut-enriched diet (43 g walnuts/day)
Number of subjects: 194
Study 28984822 — intervention group
Group type: COMPARATOR
Intervention: Control (nut-free diet)
Number of subjects: 194
Study 26039534 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan treatment for 7 days, lowering blood pressure by 5/2 mmHg from day 2 onwards.
Number of subjects: 2029
Study 26039534 — intervention group
Group type: COMPARATOR
Intervention: Placebo control group.
Number of subjects: 2029
Study 23672632 — intervention group
Group type: EXPERIMENTAL
Intervention: linagliptin added to metformin and sulphonylurea
Number of subjects: 192
Study 23672632 — intervention group
Group type: COMPARATOR
Intervention: placebo added to metformin and sulphonylurea
Number of subjects: 192
Study 21742842 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosol EZ measles vaccine for 2.5 minutes
Number of subjects: 113
Study 21742842 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous measles vaccine
Number of subjects: 113
Study 18569468 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular weight heparin (Enoxaparin sodium 0.2 ml, 20 mg, once daily subcutaneously)
Number of subjects: 340
Study 18569468 — intervention group
Group type: COMPARATOR
Intervention: No treatment (folic acid tablets 0.5 mg daily until 13 weeks gestation)
Number of subjects: 340
Study 17127550 — intervention group
Group type: EXPERIMENTAL
Intervention: GABA medications
Number of subjects: 85
Study 17127550 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenergic blockers
Number of subjects: 85
Study 17127550 — intervention group
Group type: EXPERIMENTAL
Intervention: Low withdrawal severity
Number of subjects: 85
Study 14679156 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily tobramycin (n = 29)
Number of subjects: 60
Study 14679156 — intervention group
Group type: COMPARATOR
Intervention: Every 8 hours tobramycin (n = 31)
Number of subjects: 60
Study 14679156 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily tobramycin (n = 26)
Number of subjects: 60
Study 14679156 — intervention group
Group type: COMPARATOR
Intervention: Every 8 hours tobramycin (n = 27)
Number of subjects: 60
Study 10946430 — intervention group
Group type: EXPERIMENTAL
Intervention: Community intervention to reduce delay in MI symptoms to hospital arrival
Number of subjects: 10
Study 10946430 — intervention group
Group type: COMPARATOR
Intervention: Control communities
Number of subjects: 10
Study 9505990 — intervention group
Group type: EXPERIMENTAL
Intervention: Butorphanol nasal spray (1 mg)
Number of subjects: 24
Study 9505990 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg)
Number of subjects: 24
Study 9505990 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of butorphanol nasal spray (1 mg) and metoclopramide (10 mg)
Number of subjects: 24
Study 8489831 — intervention group
Group type: EXPERIMENTAL
Intervention: Ionic contrast media
Number of subjects: 0
Study 8489831 — intervention group
Group type: COMPARATOR
Intervention: Non-ionic contrast media
Number of subjects: 0
Study 8489831 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-registration trials
Number of subjects: 0
Study 8489831 — intervention group
Group type: COMPARATOR
Intervention: Post-marketing surveillances
Number of subjects: 0
Study 3789297 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic injection of carotid sinus nerve with bupivacaine (Marcaine)
Number of subjects: 100
Study 3789297 — intervention group
Group type: COMPARATOR
Intervention: No injection (Control)
Number of subjects: 100
Study 29743322 — intervention group
Group type: EXPERIMENTAL
Intervention: Care for Stroke intervention
Number of subjects: 266
Study 29743322 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 266
Study 27742226 — intervention group
Group type: EXPERIMENTAL
Intervention: E/C/F/TAF (Tenofovir Alafenamide)
Number of subjects: 200
Study 27742226 — intervention group
Group type: COMPARATOR
Intervention: E/C/F/TDF (Tenofovir Disoproxil Fumarate)
Number of subjects: 200
Study 27742226 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups (TAF and TDF)
Number of subjects: 200
Study 24667300 — intervention group
Group type: EXPERIMENTAL
Intervention: Dacarbazine (Dac) with oblimersen sodium (7 mg/kg/day)
Number of subjects: 314
Study 24667300 — intervention group
Group type: COMPARATOR
Intervention: Dacarbazine (Dac) with placebo
Number of subjects: 314
Study 23346662 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% acetylcysteine topical gel
Number of subjects: 99
Study 20650041 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of prednisone and leflunomide (LEF)
Number of subjects: 40
Study 20650041 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy of prednisone and mycophenolate mofetil (MMF)
Number of subjects: 40
Study 18574653 — intervention group
Group type: EXPERIMENTAL
Intervention: artesunate-cotrimoxazole
Number of subjects: 182
Study 18574653 — intervention group
Group type: EXPERIMENTAL
Intervention: artesunate-amodiaquine
Number of subjects: 182
Study 15858606 — intervention group
Group type: EXPERIMENTAL
Intervention: Bubble NCPAP
Number of subjects: 18
Study 15858606 — intervention group
Group type: COMPARATOR
Intervention: VF-NCPAP
Number of subjects: 18
Study 12910485 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin supplements around the time of conception and during early pregnancy
Number of subjects: 0
Study 12910485 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplements
Number of subjects: 0
Study 12910485 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 11313659 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid - 300 mg/day for 28 days
Number of subjects: 40
Study 11313659 — intervention group
Group type: COMPARATOR
Intervention: Placebo - twice a day for 28 days
Number of subjects: 40
Study 8780542 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy (ERT)
Number of subjects: 418
Study 1610866 — intervention group
Group type: EXPERIMENTAL
Intervention: OKT3, 5 mg/day for 7 days
Number of subjects: 39
Study 1610866 — intervention group
Group type: COMPARATOR
Intervention: ALG, 15 mg/kg/day for 7 days
Number of subjects: 39
Study 1610866 — intervention group
Group type: EXPERIMENTAL
Intervention: OKT3
Number of subjects: 39
Study 1610866 — intervention group
Group type: COMPARATOR
Intervention: ALG
Number of subjects: 39
Study 6734079 — intervention group
Group type: EXPERIMENTAL
Intervention: Plethysmographic technique for measuring arterial compliance
Number of subjects: 31
Study 6734079 — intervention group
Group type: EXPERIMENTAL
Intervention: Calculation from pulse wave velocity and brachial artery dimension
Number of subjects: 31
Study 6734079 — intervention group
Group type: EXPERIMENTAL
Intervention: Plethysmographic technique
Number of subjects: 31
Study 30413191 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined-intervention group (one-session individual intervention with detailed information on functioning, activities of daily living, physical activity, nutrition, assistive devices, instructions on pain management and exercises)
Number of subjects: 151
Study 30413191 — intervention group
Group type: COMPARATOR
Intervention: Routine-care-plus-placebo group
Number of subjects: 151
Study 30413191 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined-intervention group
Number of subjects: 151
Study 27428201 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan (1000 mg/d, n = 40)
Number of subjects: 80
Study 27428201 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 40)
Number of subjects: 80
Study 24929461 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi group (n = 24)
Number of subjects: 72
Study 24929461 — intervention group
Group type: COMPARATOR
Intervention: Exercise group (n = 24)
Number of subjects: 72
Study 24929461 — intervention group
Group type: COMPARATOR
Intervention: Wait-list group (n = 24)
Number of subjects: 72
Study 23023573 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesh Plug (MP)
Number of subjects: 300
Study 23023573 — intervention group
Group type: COMPARATOR
Intervention: Shouldice (S)
Number of subjects: 300
Study 20934559 — intervention group
Group type: EXPERIMENTAL
Intervention: Darapladib (160 mg enteric-coated tablets)
Number of subjects: 15828
Study 20934559 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15828
Study 18797468 — intervention group
Group type: EXPERIMENTAL
Intervention: ECMF (epirubicin followed by cyclophosphamide, methotrexate and 5‐fluorouracil)
Number of subjects: 2021
Study 18797468 — intervention group
Group type: EXPERIMENTAL
Intervention: ECMF
Number of subjects: 2021
Study 18797468 — intervention group
Group type: COMPARATOR
Intervention: CMF
Number of subjects: 2021
Study 18797468 — intervention group
Group type: COMPARATOR
Intervention: ECMF and CMF
Number of subjects: 2021
Study 16247099 — intervention group
Group type: EXPERIMENTAL
Intervention: North American ginseng extract (2 capsules per day for 4 months)
Number of subjects: 279
Study 16247099 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 capsules per day for 4 months)
Number of subjects: 279
Study 12080314 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid fixation with three 2-mm bicortical position screws
Number of subjects: 0
Study 12080314 — intervention group
Group type: COMPARATOR
Intervention: Wire fixation with inferior border wires and 6 weeks of skeletal maxillomandibular fixation with 24-gauge wires
Number of subjects: 0
Study 12080314 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Rigid and Wire)
Number of subjects: 0
Study 10207506 — intervention group
Group type: EXPERIMENTAL
Intervention: GH (up to 0.25 U/kg/week in daily doses)
Number of subjects: 20
Study 10207506 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 10207506 — intervention group
Group type: EXPERIMENTAL
Intervention: GH
Number of subjects: 20
Study 7789626 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-modified frequently sampled intravenous glucose tolerance test (FSIVGTT)
Number of subjects: 12
Study 7789626 — intervention group
Group type: COMPARATOR
Intervention: Isoglycemic hyperinsulinemic clamp
Number of subjects: 12
Study 2192563 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (60 mg/day) plus behavior modification
Number of subjects: 45
Study 2192563 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus behavior modification
Number of subjects: 45
Study 435014 — intervention group
Group type: EXPERIMENTAL
Intervention: peer‐oriented incare
Number of subjects: 466
Study 435014 — intervention group
Group type: COMPARATOR
Intervention: intensive incare
Number of subjects: 466
Study 435014 — intervention group
Group type: EXPERIMENTAL
Intervention: network
Number of subjects: 466
Study 435014 — intervention group
Group type: EXPERIMENTAL
Intervention: no‐network
Number of subjects: 466
Study 31990801 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolene explants (cleaned)
Number of subjects: 205
Study 31990801 — intervention group
Group type: COMPARATOR
Intervention: Unused ('exemplar') TVT specimens (with and without intentional oxidation)
Number of subjects: 205
Study 30659676 — intervention group
Group type: EXPERIMENTAL
Intervention: Double anodal tDCS
Number of subjects: 15
Study 30659676 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 15
Study 28333512 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive affect skills intervention
Number of subjects: 159
Study 28333512 — intervention group
Group type: COMPARATOR
Intervention: Attention-matched control condition
Number of subjects: 159
Study 26005977 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelatin sponge insertion (group A)
Number of subjects: 278
Study 26005977 — intervention group
Group type: COMPARATOR
Intervention: Non-insertion (group B)
Number of subjects: 278
Study 23856015 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-focused intervention delivered in community pharmacies
Number of subjects: 144
Study 23856015 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 144
Study 23856015 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-focused intervention
Number of subjects: 144
Study 21043792 — intervention group
Group type: COMPARATOR
Intervention: RPc (ridge preservation with primary wound closure)
Number of subjects: 11
Study 21043792 — intervention group
Group type: EXPERIMENTAL
Intervention: RPe (ridge preservation without primary wound closure)
Number of subjects: 11
Study 19285600 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistant starch
Number of subjects: 20
Study 19285600 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn bran
Number of subjects: 20
Study 19285600 — intervention group
Group type: EXPERIMENTAL
Intervention: Polydextrose
Number of subjects: 20
Study 19285600 — intervention group
Group type: COMPARATOR
Intervention: Low-fiber muffin (LF)
Number of subjects: 20
Study 17091752 — intervention group
Group type: EXPERIMENTAL
Intervention: Clean Intermittent Self-Catheterization (CISC) performed 1-4 times/24 hours
Number of subjects: 80
Study 17091752 — intervention group
Group type: COMPARATOR
Intervention: Indwelling Catheter with fortnightly catheter change
Number of subjects: 80
Study 14722148 — intervention group
Group type: EXPERIMENTAL
Intervention: DSEC (dietary supplement containing ephedra [12 mg] and caffeine [40 mg])
Number of subjects: 15
Study 11552024 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling garment at 7 degrees C (active cooling)
Number of subjects: 10
Study 11552024 — intervention group
Group type: COMPARATOR
Intervention: Sham cooling at 26 degrees C (control)
Number of subjects: 10
Study 9756228 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice nurses identifying patients drinking above recommended guidelines
Number of subjects: 1852
Study 9756228 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral to GP by practice nurses
Number of subjects: 1852
Study 9756228 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening instruments and brief interventions by practice nurses
Number of subjects: 1852
Study 8147341 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat, high-fiber diet (Rec diet)
Number of subjects: 21
Study 3210128 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group instructed to fake depression, provided with a clinical description of the disorder, and offered a cash incentive for convincing test display of depression.
Number of subjects: 58
Study 3210128 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly described in the abstract).
Number of subjects: 58
Study 31326321 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared Decision Making (SDM) coupled with Expectation Questionnaire-Pgm
Number of subjects: 90
Study 31326321 — intervention group
Group type: COMPARATOR
Intervention: Traditional clinical interview
Number of subjects: 90
Study 31326321 — intervention group
Group type: COMPARATOR
Intervention: Shared Decision Making (SDM)
Number of subjects: 90
Study 28748974 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberries (40 g)
Number of subjects: 25
Study 28748974 — intervention group
Group type: COMPARATOR
Intervention: Control (no cranberries)
Number of subjects: 25
Study 26053149 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher P3b amplitudes to target stimuli in a go/no-go task
Number of subjects: 239